Precision engineering at the scale of digestion.
SiPore® starts with a familiar material - silica - and turns it into a precisely engineered functional technology. The innovation lies in the physical design of the particle: its size, structure and controlled pore architecture are engineered to create a specific interaction with digestive enzymes. That particle design underpins both the function of SiPore® and a growing intellectual-property portfolio protecting the technology and its applications.
The material is only the starting point.
Silicon dioxide is the material basis of SiPore®. What makes SiPore® distinctive is the way that material is engineered. The particles are manufactured with carefully controlled physical characteristics, including particle size and porosity. The pore structure gives SiPore® its function during digestion.
- 01 — SILICON DIOXIDEThe material foundation.
- 02 — PARTICLE ENGINEERINGPhysical characteristics are controlled during manufacture.
- 03 — PRECISE PORE STRUCTUREInternal pore architecture is designed for selective interaction with digestive enzymes.
- 04 — FUNCTION DURING DIGESTIONA portion of amylase and lipase can be entrapped, helping make carbohydrate and fat breakdown more gradual.
Core statement Silica is the material. The engineered particle is the technology.
Function designed into the structure.
SiPore®’s function is physical. Its precisely controlled pores create a size-selective environment that allows the particles to interact with digestive enzymes during digestion. Evidence from preclinical research supports the physical entrapment of enzymes such as amylase and lipase within the pore structure. This enables SiPore® to influence digestion locally in the gastrointestinal tract without needing to enter the bloodstream.
Particle size Pore structure Enzyme fit Gut-local function
Protecting the platform from multiple angles.
The SiPore® intellectual-property portfolio has been built around multiple aspects of the platform. This overview describes the structure of the portfolio and does not interpret individual patent claims.
Protection relating to highly structured porous silica materials and their properties.
Protection around applications of porous silica in defined health and functional contexts.
Protection covering specific SiPore® formulations and ways of bringing the technology into finished products.
Additional patent families extend the platform into areas beyond the original metabolic-health application.
This layered approach allows the IP portfolio to evolve as the platform moves into new formats, uses and commercial categories.
Seven patent families across multiple application areas.
The current portfolio spans metabolic health, oral health and additional applications.
- METABOLIC HEALTHFamilies 1–4
- ORAL HEALTHFamilies 5–6
- ADDITIONAL APPLICATIONSFamily 7
7 patent families • 10+ granted patents • protection pursued across major global markets
View patent details +
Medical useFAMILY 1 • METABOLIC HEALTH
- PCT
- EP2013/073200
- Publication
- WO2014072363
- Portfolio status
- Granted in multiple major territories according to the September 2026 portfolio, including the United States, Europe, Japan, Canada and Australia.
- Broad portfolio theme
- use of porous silica as a pharmaceutical or dietary active ingredient.
Composition of matterFAMILY 2 • METABOLIC HEALTH
- PCT
- EP2019/055219
- Publication
- WO2019166656
- Portfolio status
- The supplied portfolio records U.S. grant status, with European protection also pursued.
- Broad portfolio theme
- highly structured porous silica materials and biological uses thereof.
SiPore21 formulation — medical useFAMILY 3 • METABOLIC HEALTH
- PCT
- EP2023/073128
- Publication
- WO2024042122
- Portfolio status
- Applications pursued across multiple international markets.
- Broad portfolio theme
- oral formulations comprising porous silica particles and medical uses thereof.
SiPore21 formulation — foodFAMILY 4 • METABOLIC HEALTH
- PCT
- EP2023/073130
- Publication
- WO2024042123
- Portfolio status
- Applications pursued in major markets including China, Europe and the United States.
- Broad portfolio theme
- dietary-supplement formulations comprising silica particles.
Oral-care applicationsFAMILY 5 • ORAL HEALTH
- PCT
- EP2023/052641
- Publication
- WO2023148307
- Portfolio status
- Applications filed across a broad group of international territories.
- Broad portfolio theme
- oral-care compositions comprising porous silica particles.
Chewable formatsFAMILY 6 • ORAL HEALTH
- PCT
- PCT/EP2024/072639
- Publication
- WO2025032243
- Portfolio status
- Applications include major territories such as Europe, the United States, Japan, Canada and China according to the supplied portfolio.
- Broad portfolio theme
- chewable compositions containing porous silica particles.
Antibacterial applicationsFAMILY 7 • ADDITIONAL APPLICATIONS
- PCT
- PCT/EP2024/072607
- Publication
- WO2025032230
- Portfolio status
- Applications are being pursued in Europe and the United States according to the supplied portfolio.
- Broad portfolio theme
- use of porous-silica compositions in preventing or inhibiting bacterial growth.
One engineered platform. Multiple application areas.
The physical properties of SiPore® can be engineered for different functional applications. Metabolic health is the most clinically developed expression of the platform today, while the underlying material- and pore-engineering capabilities create opportunities in additional categories.
- METABOLIC HEALTHESTABLISHED / MOST ADVANCED
- ORAL HEALTHEXPANDING
- PET HEALTHRESEARCH & PARTNERSHIP
- FUNCTIONAL FOODEXPLORATORY
- PROFESSIONAL ORAL HEALTHLONGER-TERM
SiPore® can reach the market in different ways.
SIGRID brings SiPore® to consumers through products sold via SigridLife.com.
SiPore® Pro brings the technology into practitioner-facing products and professional education.
External companies can develop products using the technology under the Powered by SiPore® endorsement.
The function belongs to the particle, not the package.
SiPore® is not defined by a capsule, gel, powder or any other single delivery format. The technology resides in the engineered porous particle. That creates flexibility to develop different finished-product formats while preserving the central SiPore® principle: precision-engineered material designed for a specific local function.
Different formats. One engineered platform.
Research creates new IP. IP enables new research.
SiPore® began with a material-science question:
The question Can porous silica be engineered to perform a controlled biological function? Research into that question led to new particle designs, new applications and new intellectual property. As the platform develops, the same cycle continues.
- RESEARCHUnderstand a biological or functional opportunity.
- ENGINEERINGDesign the particle structure for the intended role.
- PROTECTBuild intellectual-property protection around the innovation.
- APPLYTranslate the technology into products and new application areas.
- LEARNGenerate new evidence and identify the next opportunity.
↺ back to RESEARCH
Build with SiPore®.
SiPore Technologies develops and protects the SiPore® platform and works with partners to bring the technology into new products, categories and markets. For licensing, product development or strategic partnership discussions:
The innovation is not the existence of silica.
It is the precision engineering of the particle and its pore structure - and the intellectual property built around that engineering and its applications.